|
ZNF548 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.04660000244917E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50069956461607E-11 |
| Normal-vs-Stage2 |
2.506200E-02 |
| Normal-vs-Stage3 |
5.582400E-02 |
| Normal-vs-Stage4 |
6.909800E-01 |
| Stage1-vs-Stage2 |
1.004440E-01 |
| Stage1-vs-Stage3 |
6.554200E-04 |
| Stage1-vs-Stage4 |
3.88370000000693E-05 |
| Stage2-vs-Stage3 |
4.025800E-01 |
| Stage2-vs-Stage4 |
9.536200E-02 |
| Stage3-vs-Stage4 |
2.723400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56010000029738E-07 |
| Normal-vs-AfricanAmerican |
5.399500E-02 |
| Normal-vs-Asian |
8.404300E-02 |
| Caucasian-vs-AfricanAmerican |
6.018600E-01 |
| Caucasian-vs-Asian |
2.172200E-01 |
| AfricanAmerican-vs-Asian |
2.099400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.3503999999972E-05 |
| Normal-vs-Female |
2.05009999976191E-07 |
| Male-vs-Female |
4.843700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.903500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.95089999499976E-08 |
| Normal-vs-Age(61-80Yrs) |
3.234500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.850600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.318600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.703000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.675000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.485500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.515800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.518200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.789000E-04 |
| Normal-vs-Grade 2 |
8.33689783874547E-11 |
| Normal-vs-Grade 3 |
3.000600E-04 |
| Normal-vs-Grade 4 |
8.424400E-02 |
| Grade 1-vs-Grade 2 |
8.131900E-02 |
| Grade 1-vs-Grade 3 |
7.141300E-03 |
| Grade 1-vs-Grade 4 |
2.07639999971754E-07 |
| Grade 2-vs-Grade 3 |
9.902300E-03 |
| Grade 2-vs-Grade 4 |
1.27460042520511E-10 |
| Grade 3-vs-Grade 4 |
1.81456999999163E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.92068583260152E-14 |
| Normal-vs-ccB subtype |
1.837710E-02 |
| ccA subtype-vs-ccB subtype |
1.93813999999071E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70391999999575E-05 |
| Normal-vs-N1 |
1.163160E-01 |
| N0-vs-N1 |
1.541090E-03 |
|
|
